Open main menu
Search Ctrl + K
Free Trial
Loading...
Jaguar Health, Inc.
Watch
Pharmaceutical Preparations
NASDAQ.JAGX
200 Pine Street Suite 400, San Francisco, CA, 94104
Categorized
Chronological
Ownership by Owner
Insider Transactions
Institutional Owners
Filings by Form Type
Transcripts
Your Highlights
Search Within Documents
Key Exhibits
Articles & Bylaws
Indentures
Material contracts
Plans of Reorganization
Underwriting Agreements
External Links
Google Finance
SEC EDGAR
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Prospectuses and Registrations
424B5
Prospectus Filed Pursuant To Rule 424(b)(5).
13 Nov 24
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
13 Aug 24
424B5
Prospectus Filed Pursuant To Rule 424(b)(5).
18 Jul 24
424B5
Prospectus Filed Pursuant To Rule 424(b)(5).
23 May 24
424B3
Prospectus Filed Pursuant To Rule 424(b)(3).
01 May 24
424B5
Prospectus Filed Pursuant To Rule 424(b)(5).
02 Apr 24
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
01 Apr 24
Ownership
4
Bochnowski James J
10 Oct 24
4
Jayasuriya Anula
10 Oct 24
4
Micek John
10 Oct 24
4
Conte Lisa A
10 Oct 24
4
Wolin Jonathan S.
10 Oct 24
4
Lizak Carol R.
10 Oct 24
4
King Steven R.
10 Oct 24
Financials
10-Q
Quarterly Filing
13 Nov 24
10-Q
Quarterly Filing
13 Aug 24
10-Q
Quarterly Filing
14 May 24
10-K/A
Fiscal Year 2023
17 Apr 24
10-K
Fiscal Year 2023
01 Apr 24
10-Q
Quarterly Filing
14 Nov 23
10-Q
Quarterly Filing
14 Aug 23
Other
ARS
Scanned Paper Annual Report Submission.
28 May 24
EFFECT
Notice Of Effectiveness For A Previously Filed Sec Document.
01 May 24
S-3
Registration Statement Under The Securities Act.
22 Apr 24
ARS
Scanned Paper Annual Report Submission.
01 Jun 23
D
Notice Of An Exempt Offering Of Securities Under Regulation D.
11 May 23
D
Notice Of An Exempt Offering Of Securities Under Regulation D.
11 May 23
10-K/A
Amended Annual Report Under Section 13 Or 15(d) Of The Exchange Act.
28 Apr 23
News
8-K
Entry Into A Material Definitive Agreement, Financial Statements And Exhibits
13 Nov 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
13 Nov 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
13 Aug 24
8-K
Regulation Fd Disclosure, Financial Statements And Exhibits
23 Jul 24
8-K
Entry Into A Material Definitive Agreement, Financial Statements And Exhibits
18 Jul 24
8-K
Unregistered Sales Of Equity Securities, Financial Statements And Exhibits
16 Jul 24
8-K
Other Events, Financial Statements And Exhibits
26 Jun 24
Proxies
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
31 May 24
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
21 May 24
PRE 14A
Preliminary Proxy Statement Not Yet Definitive.
10 May 24
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
15 Mar 24
PRE 14A
Preliminary Proxy Statement Not Yet Definitive.
05 Mar 24
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
31 May 23
PRE 14A
Preliminary Proxy Statement Not Yet Definitive.
16 May 23